Bajaj Finserv AMC has announced the launch of its latest offering, the Bajaj Finserv Healthcare Fund, an open-ended equity scheme aimed at long-term growth through investments in the pharmaceutical and healthcare sectors. The New Fund Offer (NFO) opens on December 6 and closes on December 20, 2024. The fund, benchmarked against the BSE Healthcare Total Return Index (TRI), targets sectors such as pharmaceuticals, diagnostics, hospitals, and medical equipment. It aims to invest at least 80% of its portfolio in companies associated with the healthcare sector.
Ganesh Mohan, CEO of Bajaj Finserv AMC, emphasized the fund’s alignment with global healthcare trends, stating, “This fund offers investors a chance to leverage the robust growth in healthcare and wellness, delivering long-term opportunities in a dynamic sector.” CIO Nimesh Chandan highlighted the sector’s potential, noting, “By focusing on companies poised to lead profit pools and investing in key megatrends, we aim to uncover growth stories in healthcare.” The fund offers both Growth and IDCW options, with a minimum investment of ₹500.
The fund’s launch is expected to resonate with investors in Siliguri, known for its rising interest in diversified investment avenues. As Siliguri emerges as a key economic hub, the focus on healthcare investments aligns with the region’s growing demand for innovative financial products that promise long-term wealth creation. Managed jointly by Nimesh Chandan, Sorbh Gupta (equity), and Siddharth Chaudhary (debt), the fund applies an exit load of 1% for redemptions within three months. The initiative reflects Bajaj Finserv AMC’s commitment to leveraging trends in health and wellness for wealth creation.
